Title: Vitamin D: A Review on Functions and Requirements (Part II)
Authors: Dr Vishakha S. Patil, Dr Rohini S. Mali, Dr Alpana Moghe
DOI: https://dx.doi.org/10.18535/jmscr/v4i12.93
Abstract
Vitamin D a fat soluble vitamin is also a hormone which along with its effect on bone mineralization, exerts its effect on cells by binding to Vitamin D receptor present on most cell types in the body. Its broad spectrum of activities in skin, immune system, cell differentiation and development underlines its crucial role in regulation of metabolism. The present review is an attempt to provide compiled information on the crucial role played by this vitamin in controlling the functions of body tissues. This review also highlights necessary intake values, dietary sources, normal serum levels and toxicity associated with excess intake. The review article intends to spread the knowledge that vitamin D is absolutely critical for good health and disease prevention.
Keywords- Inactive Vitamin D3, Calcitriol, Vitamin D deficiency, Immune response, Cancer prevention.
References
1. Evans R M (1998). The steroid and thyroid hormone receptor superfamily. Science 40: 889–895.
2. Mark R, Haussler MR, Haussler et al (2011). Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)2D3: Genomic and non-genomic mechanisms. Best Practice & Research Clinical Endocrinology & Metabolism 25: 543–559.
3. DeLuca HF Ed (1979). Vitamin D. Metabolism and function. In DeLuca HF Ed. Monographs on Endocrinology. Berlin: Springer-Verlag Pg. 1–80.
4. Yamamoto M, Kawanoke Y, Takahashi H, Shimazawa E, Kimura S, Ogata E (1984). Vitamin D deficiency and renal calcium transport in the rat. J Clin Invest 74: 507–553.
5. Van Leeuwen JP, Van Driel M, Van den Bemd GJ, Pols HA (2001) Vitamin D control of osteoblast function and bone extracellular matrix mineralization. Crit Rev Eukaryot Gene Expr 11:199–226.
6. Owen TA, Aronow MS, Barone LM, Bettencourt B, Stein GS, Lian JB (1991). Pleiotropic effects of Vitamin D on osteoblast gene expression are related to the proliferative and differentiated state of the bone cell phenotype: dependency upon basal levels of gene expression, duration of exposure, and bone matrix competency in normal rat osteoblast cultures. Endocrinology 128:1496–1504.
7. Bar-Shavit Z, Teitelbaum SL, Reitsma P, Hall A, Pegg LE, Trial J, Kahn AJ (1983). Induction of monocytic differentiation and bone resorption by 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 80:5907– 5911.
8. Yasuda H, Kigashio K, Suda T (2005). Vitamin D and osteoclastogenesis. In: Feldman D, Pike JW, Glorieux FH, eds. Vitamin D 2nd edn. San Diego, C.A: Elsevier Academic Press; 665–685.
9. Garabedian M, Tanaka Y, Holick MF, DeLuca HF (1974). Response of intestinal calcium transport and bone calcium mobilization to 1,25-dihydroxyvitamin D3 in thyroparathyroidectomized rats. Endocrinology 94:1022–1027.
10. Adams JS, Hewison M (2008). Unexpected actions of Vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab 4:80–90.
11. Tiosano D, Wildbaum G, Gepstein V, Verbitsky O, Weisman Y et Al (2013). The role of vitamin D receptor in innate and adaptive immunity: Astudy in hereditary Vitamin D resistant Rickets patients. J Clin Endocrinol Metab 98: 1685-1693.
12. Liu PT, Stenger S, Wenzel L et al (2006). Activation of human TLR2/1 t triggers a Vitamin D receptor-dependent antimicrobial response. Science 311:1770-1773.
13. Tian-Tian Wang, Frederick P. Nestel, Veronique Bourdeau et al (2004). Cutting edge: 1, 25-Dihydroxyvitamin D3 Is a direct Inducer of Antimicrobial peptide gene expression. The Journal of Immunology 173: 2909-2912.
14. Holla LI, Jurajda M, Fassmann A, Dvorakova N, Znojil V, Vacha J (2004). Genetic variations in the matrix mettaloproteinase-1 promoter and risk of susceptibility and/or severity of Chronic Periodontitis in the Czech population. J Clin Periodontol 31:685- 90.
15. Dietrich T, Nunn M, Dawson-Hughes B, Bischoff- Ferrari HA (2005).Association between serum concentrations of 25-hydroxyvitamin D and gingival inflammation. Am J Clin Nutr 82: 575-580.
16. Garcia MN, Hildebolt CF, Miley DD, Dixon Da, Couture RA, Spearie CL, et al (2011).One Year effects of Vitamin D and calcium supplementation on Chronic Periodontitis. J Periodontol 82: 25-32.
17. Naito M, Miyaki K, Naito T, Zhang L, Hoshi K Hara A et al (2007). Association between Vitamin D receptor gene haplotypes and Chronic Periodontitis among Japanese men. Int J Med Sci.4(4):216-22.
18. Park KS, Nam JH, Choi J (2006). The short Vitamin D Receptor is associated with increased risk for generalized aggressive Periodontitis. J Clin Periodontol 33(8): 524-8.
19. Anand N. Chandrasekaran SC, Rajput NS. Vitamin D and Periodontal health. Current concepts. J Indian Soc Periodontol 17: 302-308.
20. Abe E, Miura C, Sakagami H, et al (1981). Differentiation of mouse myeloid leukemia cells induced by 1a,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 78:4990–4994.
21. Wilson AJ, Velcich A, Arango D, et al (2002). Novel detection and differential utilization of a c-myc transcriptional block in colon cancer chemoprevention. Cancer Res 62: 6006–6010.
22. Wang QM, Jones JB, Studzinski GP (1996). Cyclin- dependent kinase inhibitor p27 as a mediator of the G1-S phase block induced by1,25-dihydroxyvitamin D3 in HL60 cells. Cancer Res 56:264–267.
23. Verlinden L, Verstuyf A, Convents R, Marcelis S, Van Camp M, Bouillon R (1998). Action of 1,25(OH)2D3 on the cell cycle genes, cyclin D1, p21 and p27 in MCF-7 cells. Mol Cell Endocrinol 142:57–65.
24. Godyn H J, Xu J, Zhang F, Kolla S, Studzinski GP (1994). A dual block to cell cycle progression in HL 60 cells exposed to analogues of Vitamin D3. Cell Prolif 27: 37- 46.
25. Eisman JA, Koga M, Sutherland RL, Barkla DH, Tutton PJM (1989). 1,25-Dihydroxy-vitamin D3 and the regulation of human cancer cell replication. Proc Soc Exp Biol Med 191:221–226.
26. Dokoh S, Donaldson CA, Marion SL, Pike JW, Haussler MR (1983). The ovary: a target organ for 1,25-dihydroxyvitamin D3Endocrinology 112:200–206.
27. Stumpf WE, Sar M, and Reid FA(1979). Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary and parathyroid. Science 206:1188-1190.
28. Hosomi J, Hosoi J, Abe E, Suda T, Kuroki T (1983). Regulation of terminal differenti-ation of cultured mouse epidermal cells by α,25-dihydroxyvitamin D3.Endocrinology 113:1950–1957.
29. Holick MF, Smith EL, Walworth NC (1986). Effect of 1α,25-dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions. J Invest Dermatol 86:709–714.
30. DeLuca HF (1971). Active compounds. In: The Vitamins Chemistry, Physiology, Pathology, Methods, edited by WH Sebrell Jr, and RS Harris. New York: Academic chap. IV, pp 223–232.
31. Hosomi J, Hosoi J, Abe E, Suda T, Kuroki, T (1983). Regulation of terminal differentiation of cultured mouse epidermal cells by 1α,25-dihydroxyvitamin D3. Endocrinology 113:1950–1957.
32. Sum J, Bikle DD, Mancianti ML, Pillai S (1994). 1,25-Dihydroxyvitamin D3 potentiates the keratinocyte response to calcium. J Biol Chem 269:14723–14729.
33. Pillai S, Bikle DD (1991). Role of intracellular free calcium in the cornified envelope formation of keratinocytes: differences in the mode of action of extracellular calcium and 1,25 dihydroxyvitamin D. J Cell Physiol 146:94–100.
34. Bikle DD (1997). Vitamin D and skin. In: Vitamin D edited by Feldman D, Glorieux FH, and Pike JW, San Diego CA: Academic, chap. 25, pp 379–394.
35. Yang S, Smith C, Prahl JM, DeLuca HF (1993). Vitamin D deficiency suppresses cell-mediated immunity in vivo. Arch Biochem Biophys 303:98–106.
36. Cantorna MT, Hayes CE, DeLuca HF (1996). 1,25- Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci USA 93:7861– 7864.
37. Cantorna MT, Hayes CE, DeLuca HF (1998). 1,25- Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J Nutr 128:68–72.
38. Zella JB, McCary LC, DeLuca HF (2003). Oral administration of 1,25-dihydroxyvitamin D3 completely protects NOD mice from insulin- dependent diabetes mellitus. Arch Biochem Biophys 417:77–80.
39. Institute of Medicine. Dietary reference intakes for calcium and Vitamin D. Washington,DC: Institute of Medicine of the National Academies. 2010.
40. Vitamin D- The Master Key to Optimal Health by Dr. Robert Heaney 2009. Visit Mercola Video Library online Reference.
41. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B (2006). Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84:18 –28.
42. Holick MF, Mac Laughlin JA, Doppelt SH (1981). Factors that influence the cutaneous photosynthesis of previtamin D3. Science 211: 590-3.
43. Webb AR, de Costa BR, Holick MF (1989). Sunlight regulates the cutaneous production of Vitamin D3 by causing its photodegradation. J Clin Endocrinol Metab 68:882-7.
44. Clemens TL, Adams JS, Henderson SL, Holick MF (1982).Increased skin pigment reduces the capacity of the skin to synthesize Vitamin D. Lancet 1:74-6.
45. Matsuoka LY, Ide L, Wortsman J, MacLaughlin JA, Holick MF (1987). Sunscreens suppress cutaneous Vitamin D synthesis. J Clin Endocrinol Metab 64:1165-8.
46. Matsuoka LY, Wortsman J, Dannen Berg MJ, Hollis BW, Lu Z,Holick MF (1992).Clothing prevents ultraviolet B radiation –dependent photosynthesis of Vitamin D3. J Clin Endocrinol Metab 75:1099-103.
47. Suellan Go Yao, James Burke Fine (2012). A Review of Vitamin D as It Relates to Periodontal Disease. Compendium of Continuing Education In Dentistry.
48. Holick MF (2009). Vitamin D Status: Measurement, Interpretation, and Clinical Application. Ann Epidemiol 19 (2): 73-78.
49. Hathcock JN, Shao A, Vieth R, Heaney R (2007). Risk assessment for Vitamin D. Am J Clin Nutr 85: 6 –18.
50. Marx SJ (1995). Vitamin D and other calciferols. In:Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The Metabolic and Molecular Bases of Inherited Disease. Vol. 2, 7th ed. New York: McGraw-Hill, pp 3103–3104.
51. Kramer B, Kanof A (1954). VIII. Requirements of human beings. In: Sebrell Jr WH, Harris RS, editors. The Vitamins. Chemistry, Physiology, Pathology. Vol. II. NewYork: Academic Pres, pp257–266.
52. Hathcock JN, Shao A, Vieth R, Heaney R (2007). Risk assessment for Vitamin D. Am J Clin Nutr. 85:6–18.